Cargando…
The eukaryotic translation initiation factor eIF4E reprograms alternative splicing
Aberrant splicing is typically attributed to splice‐factor (SF) mutation and contributes to malignancies including acute myeloid leukemia (AML). Here, we discovered a mutation‐independent means to extensively reprogram alternative splicing (AS). We showed that the dysregulated expression of eukaryot...
Autores principales: | Ghram, Mehdi, Morris, Gavin, Culjkovic‐Kraljacic, Biljana, Mars, Jean‐Clement, Gendron, Patrick, Skrabanek, Lucy, Revuelta, Maria Victoria, Cerchietti, Leandro, Guzman, Monica L, Borden, Katherine L B |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10068332/ https://www.ncbi.nlm.nih.gov/pubmed/36843541 http://dx.doi.org/10.15252/embj.2021110496 |
Ejemplares similares
-
The eukaryotic translation initiation factor eIF4E elevates steady-state m(7)G capping of coding and noncoding transcripts
por: Culjkovic-Kraljacic, Biljana, et al.
Publicado: (2020) -
The Cap-Binding Complex CBC and the Eukaryotic Translation Factor eIF4E: Co-Conspirators in Cap-Dependent RNA Maturation and Translation
por: Mars, Jean-Clement, et al.
Publicado: (2021) -
Understanding and Targeting the Eukaryotic Translation Initiation Factor eIF4E in Head and Neck Cancer
por: Culjkovic, Biljana, et al.
Publicado: (2009) -
eIF4E3, a new actor in mRNA metabolism and tumor suppression
por: Volpon, Laurent, et al.
Publicado: (2013) -
eIF4E is a central node of an RNA regulon that governs cellular proliferation
por: Culjkovic, Biljana, et al.
Publicado: (2006)